Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/631576]Researchers: Prof David Johnson (Principal investigator) , A/Pr Glenda Gobe , Dr David Vesey , E/Pr Malcolm West , Prof Lindsay Brown
Brief description Heart attacks and kidney disease from a lack of blood flow are common causes of morbidity and have poor treatment options. Erythropoietin (epo) is a useful new treatment, but there remain some caveats to its use in humans: eg. it may cause excessive scarring during repair. Use of epo with an anti-inflammatory drug may decrease scarring and provide benefit to long-term health. We plan to carefully define the biomolecular pathways of injury and repair, to better plan this therapy for human use.
Funding Amount $AUD 361,021.75
Funding Scheme NHMRC Project Grants
Notes Standard Project Grant
- nhmrc : 631576
- PURL : https://purl.org/au-research/grants/nhmrc/631576
